Compare CCOI & OPK Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | CCOI | OPK |
|---|---|---|
| Founded | 1999 | 2007 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Telecommunications Equipment | Biotechnology: Pharmaceutical Preparations |
| Sector | Consumer Discretionary | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.1B | 967.3M |
| IPO Year | 2002 | 2011 |
| Metric | CCOI | OPK |
|---|---|---|
| Price | $18.59 | $1.20 |
| Analyst Decision | Hold | Buy |
| Analyst Count | 8 | 5 |
| Target Price | ★ $30.25 | $2.28 |
| AVG Volume (30 Days) | 867.9K | ★ 2.7M |
| Earning Date | 05-22-2026 | 01-01-0001 |
| Dividend Yield | ★ 0.30% | N/A |
| EPS Growth | N/A | ★ N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,036,104,000.00 | $713,142,000.00 |
| Revenue This Year | $4.49 | N/A |
| Revenue Next Year | $2.54 | N/A |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 10.12 | N/A |
| 52 Week Low | $15.96 | $1.11 |
| 52 Week High | $75.46 | $2.04 |
| Indicator | CCOI | OPK |
|---|---|---|
| Relative Strength Index (RSI) | 29.60 | 38.85 |
| Support Level | $25.59 | $1.19 |
| Resistance Level | $28.71 | $1.27 |
| Average True Range (ATR) | 1.92 | 0.04 |
| MACD | -0.41 | -0.00 |
| Stochastic Oscillator | 0.73 | 16.67 |
Cogent carries over one-fifth of the world's internet traffic on its network, providing high-capacity services to businesses. Cogent's corporate customers are in high-rise office buildings, where the firm provides two types of connections: dedicated internet access, which connects them to the internet, and virtual private networking, which offers an internal network for employees in different locations. Cogent's corporate customers are exclusively in North America and account for nearly half of the firm's revenue. Cogent's netcentric customers include internet service providers and content providers, to which Cogent provides internet transit. They hand traffic to Cogent in data centers and rely on Cogent to deliver it. About half of netcentric revenue is from outside the US.
OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.